Navigation Links
Early Detection Of Primary Liver Cancer Would Save Millions Of Lives

Researchers at the University of Birmingham had developed a new technology that will help in the early diagnosis of liver cancer among people who are at a high risk. It is a blood test, which measures the protein levels // combined with the computer analysis, which can detect typical; changes seen in the early liver cancer patients.

This discovery would save millions of lives because live cancer is one of the most prevalent diseases. If it were diagnosed in the early stage then it would be easy to treat the patient. The findings of the research were published in the British Journal of Cancer.

Hepatocellular carcinoma or liver cancer is the sixth most common cancer in the world and it is widespread in East Asia. Usually people with cirrhosis of the liver are more prone to develop liver cancer and hence highly sensitive tests are required to detect the disease and prevent it among the patients suffering from liver cirrhosis.

Professor Philip Johnson said that through this research they were able to distinguish people who had early liver cancer from those who without the disease. This method is very accurate and sensitive than any of the present techniques such as the existing liver cancer blood test.

But further studies have to be performed so that the test can be performed on many people.

Apart from cirrhosis of the liver various disease that cause damage to the liver like the hepatitis B and C viruses, causing Hepatitis greatly increase the risk of hepatocellular carcinoma.

Vaccinations against the hepatitis B virus are now administered to children to protect them against the disease, but there are millions of people who are already infected with the disease. In case of hepatitis C, there is no effective vaccine and the incidence of liver cancer still remains high in the global scenario.

At present high-risk groups can be screened with the help of ultrasound scans and test for the presence of a single protein in the blood called alpha-fetoprotein. Though it is a good indicator of advanced stages of the liver cancer, but it is a poor indicator of early stage liver cancer.


'"/>




Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: